1.
|
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MCC-16523, NCT01286038
|
|
2.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 65
Sponsor: Pharmaceutical / Industry
Protocol IDs: PrE0901, ELT114465, NCT01656252
|
|
3.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NHLBI
Protocol IDs: 090199, 09-H-0199, NCT00961064
|
|
4.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 112765, NCT01147809
|
|
5.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-0123, NCT01168921
|
|
6.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-0319, NCT01428635
|
|
7.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 114968, NCT01440374
|
|
8.
|
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-373, NCT01484314
|
|
9.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 10/78, NCT01488565
|
|
10.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 11/111, NCT01500538
|
|
11.
|
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: VI-Plt-01, NCT01610180
|
|
12.
|
Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-023663-18, NCT01481220
|
|
13.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: I 206111, NCI-2012-00215, NCT01550185
|
Mobile | Español
